First results from sunrise-1 in patients with bcg unresponsive high-risk non-muscle-invasive bladder cancer receiving tar-200 in combination with cetrelimab, tar-200, or cetrelimab alone Siamak Daneshmand,Michiel S. van der Heijden,Joseph M. Jacob,Andrea Necchi,Evanguelos Xylinas,David S. Morris,Philip Spiegelhalder,Daniel Zainfeld,Taek Won Kang,Justin T. Matulay,Laurence H. Belkoff,Karel Decaestecker,Harm Arentsen,Shalaka Hampras,Shu Jin,Christopher J. Cutie,Hussein Sweiti,Katherine Stromberg, Jason Martin,Giuseppe SimoneJOURNAL OF UROLOGY(2023)引用 0|浏览15暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要